http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014200449-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8c71ffbe5bd8ec629c8aba7b402ad82 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2014-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25bbb0918930c4d009d680cfa28fa295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1785bec9f9e5f661958fda7f80dc08ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52e4475e97e3d648104b01cb6117861a |
| publicationDate | 2016-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2014200449-B2 |
| titleOfInvention | Suppression of neuroendocrine diseases |
| abstract | 5 Suppression of neuroendocrine disease The present invention relates to a method for suppressing neuroendocrine disease. The therapy employs use of a non-cytotoxic protease, which is targeted to a neuroendocrine tumour cell, preferably 10 via a somatostatin or cortistatin receptor, a GHRH receptor, a ghrelin receptor, a bombesin receptor, a urotensin receptor a melanin concentrating hormone receptor 1; a KiSS-1 receptor or a prolactin releasing peptide receptor. When so delivered, the protease is internalised and inhibits secretion from said tumour cell. The present 15 invention also relates to polypeptides and nucleic acids for use in said methods. |
| priorityDate | 2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 928.